A detailed history of Nicholas Company, Inc. transactions in Globus Medical Inc stock. As of the latest transaction made, Nicholas Company, Inc. holds 359,996 shares of GMED stock, worth $29.9 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
359,996
Previous 360,191 0.05%
Holding current value
$29.9 Million
Previous $24.7 Million 4.4%
% of portfolio
0.44%
Previous 0.42%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$67.08 - $73.92 $13,080 - $14,414
-195 Reduced 0.05%
359,996 $25.8 Million
Q2 2024

Jul 24, 2024

SELL
$49.79 - $68.85 $127,960 - $176,944
-2,570 Reduced 0.71%
360,191 $24.7 Million
Q1 2024

May 14, 2024

SELL
$51.15 - $56.52 $141,174 - $155,995
-2,760 Reduced 0.76%
362,761 $19.5 Million
Q4 2023

Feb 13, 2024

BUY
$43.79 - $55.14 $212,600 - $267,704
4,855 Added 1.35%
365,521 $19.5 Million
Q3 2023

Feb 13, 2024

BUY
$49.1 - $62.37 $6.28 Million - $7.97 Million
127,816 Added 54.89%
360,666 $17.9 Million
Q3 2023

Nov 13, 2023

BUY
$49.1 - $62.37 $6.28 Million - $7.97 Million
127,816 Added 54.89%
360,666 $17.9 Million
Q2 2023

Feb 13, 2024

SELL
$52.61 - $59.54 $147,571 - $167,009
-2,805 Reduced 1.19%
232,850 $13.9 Million
Q2 2023

Aug 08, 2023

SELL
$52.61 - $59.54 $147,571 - $167,009
-2,805 Reduced 1.19%
232,850 $13.9 Million
Q1 2023

Feb 13, 2024

BUY
$51.83 - $79.63 $957,559 - $1.47 Million
18,475 Added 8.51%
235,655 $13.3 Million
Q1 2023

May 11, 2023

BUY
$51.83 - $79.63 $957,559 - $1.47 Million
18,475 Added 8.51%
235,655 $13.3 Million
Q3 2022

Feb 13, 2024

BUY
$55.32 - $67.54 $916,929 - $1.12 Million
16,575 Added 8.26%
217,180 $12.9 Million
Q3 2022

Nov 14, 2022

BUY
$55.32 - $67.54 $916,929 - $1.12 Million
16,575 Added 8.26%
217,180 $12.9 Million
Q2 2022

Feb 13, 2024

BUY
$53.08 - $81.37 $849,280 - $1.3 Million
16,000 Added 8.67%
200,605 $11.3 Million
Q2 2022

Jul 26, 2022

BUY
$53.08 - $81.37 $849,280 - $1.3 Million
16,000 Added 8.67%
200,605 $11.3 Million
Q1 2022

Feb 13, 2024

SELL
$63.68 - $75.54 $11.2 Million - $13.3 Million
-176,061 Reduced 48.82%
184,605 $13.6 Million
Q1 2022

May 11, 2022

BUY
$63.68 - $75.54 $298,340 - $353,904
4,685 Added 2.6%
184,605 $13.6 Million
Q4 2021

Feb 11, 2022

SELL
$62.62 - $79.92 $1,252 - $1,598
-20 Reduced 0.01%
179,920 $13 Million
Q3 2021

Nov 15, 2021

SELL
$76.41 - $84.06 $1,528 - $1,681
-20 Reduced 0.01%
179,940 $13.8 Million
Q2 2021

Aug 12, 2021

SELL
$61.85 - $77.53 $2,164 - $2,713
-35 Reduced 0.02%
179,960 $14 Million
Q1 2021

May 14, 2021

SELL
$60.05 - $67.74 $75,062 - $84,675
-1,250 Reduced 0.69%
179,995 $11.1 Million
Q4 2020

Feb 10, 2021

BUY
$48.89 - $65.87 $8.86 Million - $11.9 Million
181,245 New
181,245 $11.8 Million

Others Institutions Holding GMED

About GLOBUS MEDICAL INC


  • Ticker GMED
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 77,037,200
  • Market Cap $6.4B
  • Description
  • Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...
More about GMED
Track This Portfolio

Track Nicholas Company, Inc. Portfolio

Follow Nicholas Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Company, Inc. with notifications on news.